CZ20013708A3 - Nové aromatické amidy substituované ribózou, způsob jejich přípravy a jejich léčebná aplikace - Google Patents

Nové aromatické amidy substituované ribózou, způsob jejich přípravy a jejich léčebná aplikace Download PDF

Info

Publication number
CZ20013708A3
CZ20013708A3 CZ20013708A CZ20013708A CZ20013708A3 CZ 20013708 A3 CZ20013708 A3 CZ 20013708A3 CZ 20013708 A CZ20013708 A CZ 20013708A CZ 20013708 A CZ20013708 A CZ 20013708A CZ 20013708 A3 CZ20013708 A3 CZ 20013708A3
Authority
CZ
Czechia
Prior art keywords
methyl
radical
formula
compounds
alkyl
Prior art date
Application number
CZ20013708A
Other languages
Czech (cs)
English (en)
Inventor
Jacques Demassey
Michel Klich
Branislav Musicki
Original Assignee
Aventis Pharma S. A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma S. A. filed Critical Aventis Pharma S. A.
Publication of CZ20013708A3 publication Critical patent/CZ20013708A3/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/06—Benzopyran radicals
    • C07H17/065—Benzo[b]pyrans
    • C07H17/075—Benzo[b]pyran-2-ones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
CZ20013708A 1999-04-19 2000-04-18 Nové aromatické amidy substituované ribózou, způsob jejich přípravy a jejich léčebná aplikace CZ20013708A3 (cs)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9904866A FR2792320B1 (fr) 1999-04-19 1999-04-19 Nouveaux amides aromatiques substitues par un ribose, leur procede de preparation et leur application comme medicaments

Publications (1)

Publication Number Publication Date
CZ20013708A3 true CZ20013708A3 (cs) 2002-04-17

Family

ID=9544554

Family Applications (1)

Application Number Title Priority Date Filing Date
CZ20013708A CZ20013708A3 (cs) 1999-04-19 2000-04-18 Nové aromatické amidy substituované ribózou, způsob jejich přípravy a jejich léčebná aplikace

Country Status (24)

Country Link
US (1) US6579902B1 (cg-RX-API-DMAC7.html)
EP (1) EP1173455A2 (cg-RX-API-DMAC7.html)
JP (1) JP2002542253A (cg-RX-API-DMAC7.html)
KR (1) KR100693258B1 (cg-RX-API-DMAC7.html)
CN (1) CN1213055C (cg-RX-API-DMAC7.html)
AP (1) AP2001002312A0 (cg-RX-API-DMAC7.html)
AU (1) AU769514B2 (cg-RX-API-DMAC7.html)
CA (1) CA2363945A1 (cg-RX-API-DMAC7.html)
CZ (1) CZ20013708A3 (cg-RX-API-DMAC7.html)
EA (1) EA004304B1 (cg-RX-API-DMAC7.html)
FR (1) FR2792320B1 (cg-RX-API-DMAC7.html)
HK (1) HK1046690B (cg-RX-API-DMAC7.html)
HU (1) HUP0200778A3 (cg-RX-API-DMAC7.html)
ID (1) ID30562A (cg-RX-API-DMAC7.html)
IL (1) IL146018A0 (cg-RX-API-DMAC7.html)
NO (1) NO320703B1 (cg-RX-API-DMAC7.html)
NZ (1) NZ515108A (cg-RX-API-DMAC7.html)
PL (1) PL354192A1 (cg-RX-API-DMAC7.html)
SK (1) SK14842001A3 (cg-RX-API-DMAC7.html)
TR (1) TR200103009T2 (cg-RX-API-DMAC7.html)
UA (1) UA72919C2 (cg-RX-API-DMAC7.html)
WO (1) WO2000063222A2 (cg-RX-API-DMAC7.html)
YU (1) YU80301A (cg-RX-API-DMAC7.html)
ZA (1) ZA200108627B (cg-RX-API-DMAC7.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2844273B1 (fr) * 2002-09-05 2008-04-04 Aventis Pharma Sa Nouveaux composes heterocycliques, procede et intermediaires de preparation et utilisation comme medicament, notamment comme inhibiteurs de beta-lactamases et anti-bacteriens.
US7439253B2 (en) * 2002-12-06 2008-10-21 Novexel Heterocyclic compounds, their preparation and their use as medicaments, in particular as antibacterials and beta-lactamase inhibitors
KR100649357B1 (ko) * 2004-05-04 2006-11-24 제일약품주식회사 항염증 활성을 갖는 크로멘-2-온 모핵 히드록사민 산유도체, 이의 제조방법 및 이를 포함하는 염증 질환의치료를 위한 조성물
US7622451B2 (en) * 2004-11-03 2009-11-24 University Of Kansas Novobiocin analogues as neuroprotective agents and in the treatment of autoimmune disorders
AU2005301957B2 (en) * 2004-11-03 2012-02-23 Department Of Health And Human Services Novobiocin analogues as anticancer agents
US9120774B2 (en) 2004-11-03 2015-09-01 University Of Kansas Novobiocin analogues having modified sugar moieties
US8212011B2 (en) * 2004-11-03 2012-07-03 University Of Kansas Novobiocin analogues
US8212012B2 (en) * 2004-11-03 2012-07-03 University Of Kansas Novobiocin analogues having modified sugar moieties
US7960353B2 (en) * 2007-05-10 2011-06-14 University Of Kansas Novobiocin analogues as neuroprotective agents and in the treatment of autoimmune disorders
WO2010014617A1 (en) * 2008-07-28 2010-02-04 University Of Kansas Heat shock protein 90 inhibitor dosing methods
US20110082098A1 (en) * 2009-09-30 2011-04-07 University Of Kansas Novobiocin analogues and treatment of polycystic kidney disease
MX2025007723A (es) 2018-05-14 2025-08-01 Reata Pharmaceuticals Inc Biarilamidas con grupos de azucar modificados para el tratamiento de enfermedades asociadas con la trayectoria de la proteina de choque de calor

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3652536A (en) * 1969-06-02 1972-03-28 Upjohn Co Novenamine compounds and derivatives
US3890297A (en) * 1973-03-29 1975-06-17 Upjohn Co Process for n-acylating novenamine

Also Published As

Publication number Publication date
EA200101100A1 (ru) 2002-04-25
SK14842001A3 (sk) 2003-05-02
HK1046690B (zh) 2006-03-10
WO2000063222A2 (fr) 2000-10-26
NO320703B1 (no) 2006-01-16
YU80301A (sh) 2005-07-19
UA72919C2 (uk) 2005-05-16
JP2002542253A (ja) 2002-12-10
FR2792320A1 (fr) 2000-10-20
WO2000063222A3 (fr) 2001-05-31
NO20015058L (no) 2001-12-17
ZA200108627B (en) 2002-10-21
AU769514B2 (en) 2004-01-29
HUP0200778A3 (en) 2003-03-28
CN1213055C (zh) 2005-08-03
KR100693258B1 (ko) 2007-03-13
PL354192A1 (en) 2003-12-29
FR2792320B1 (fr) 2003-05-09
IL146018A0 (en) 2002-07-25
CA2363945A1 (fr) 2000-10-26
ID30562A (id) 2001-12-20
CN1357001A (zh) 2002-07-03
TR200103009T2 (tr) 2002-05-21
US6579902B1 (en) 2003-06-17
EA004304B1 (ru) 2004-02-26
KR20020008155A (ko) 2002-01-29
NZ515108A (en) 2004-01-30
HK1046690A1 (en) 2003-01-24
AU4125600A (en) 2000-11-02
AP2001002312A0 (en) 2001-12-31
EP1173455A2 (fr) 2002-01-23
HUP0200778A2 (hu) 2002-07-29
NO20015058D0 (no) 2001-10-18

Similar Documents

Publication Publication Date Title
KR100604290B1 (ko) 신규한 방향족 아미드, 제조 방법 및 의약으로서의 응용
RU2330856C2 (ru) Макролидные соединения, обладающие противовоспалительной активностью
JP2001507714A (ja) 三環式エリスロマイシン誘導体
US6579902B1 (en) Ribose-substituted aromatic amides, method for the production and use thereof as medicaments
WO2000042055A2 (en) Macrolides with anti-inflammatory activity
SK286397B6 (sk) 2-Halogén-6-O-substituované ketolidové deriváty, ich použitie, spôsob ich prípravy a farmaceutické kompozície s ich obsahom
KR20010101819A (ko) 에바멕틴 유도체
CA2258152C (fr) Nouveaux derives aromatiques substitues par un ribose, leur procede de preparation et leur application comme medicaments
AU2005210032B9 (en) Macrolides with antiinflammatory activity
JP2001518475A (ja) 環状亜リン酸およびリン酸塩
MXPA01010624A (en) Novel ribose-substituted aromatic amides, method for the production and use thereof as medicaments
JPS6155918B2 (cg-RX-API-DMAC7.html)
AU2002300839B2 (en) Novel aromatic amides, preparation method and application as medicines
JP2003535100A (ja) 細菌および原虫類感染症の治療用ハイグロマイシンa誘導体
FR2784681A1 (fr) Nouveaux amides aromatiques, leur procede de preparation et leur application comme medicaments
MXPA00006621A (en) Novel aromatic amides, preparation method and application as medicines